METERGOLINE AND CYPROHEPTADINE SUPPRESS PROLACTIN-RELEASE BY A NON-5-HYDROXYTRYPTAMINERGIC, NON-DOPAMINERGIC MECHANISM

被引:17
|
作者
BESSER, GM
DELITALA, G
GROSSMAN, A
YEO, T
机构
关键词
D O I
10.1111/j.1476-5381.1980.tb10896.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:5 / 7
页数:3
相关论文
共 28 条
  • [21] Adenosine A2A receptor antagonists as a novel non-dopaminergic therapy for Parkinson's disease: A potential mechanism of the antiparkinsonian action
    Mori, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 319 - 319
  • [22] Gamma-vinyl GABA inhibits cocaine-triggered reinstatement of drug-seeking behavior in rats by a non-dopaminergic mechanism
    Peng, Xiao-Qing
    Li, Xia
    Gilbert, Jeremy G.
    Pak, Arlene C.
    Ashby, Charles R., Jr.
    Brodie, Jonathan D.
    Dewey, Stephen L.
    Gardner, Eliot L.
    Xi, Zheng-Xiong
    DRUG AND ALCOHOL DEPENDENCE, 2008, 97 (03) : 216 - 225
  • [23] Adenosine A2A receptor antagonists as novel non-dopaminergic therapy for Parkinson's disease:: a potential mechanism of theanti-parkinsonian action
    Mori, A
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 26P - 26P
  • [24] LISURIDE, LY-141865, AND 8-OH-DPAT FACILITATE MALE-RAT SEXUAL-BEHAVIOR VIA A NON-DOPAMINERGIC MECHANISM
    AHLENIUS, S
    LARSSON, K
    PSYCHOPHARMACOLOGY, 1984, 83 (04) : 330 - 334
  • [25] Cortisol suppresses prolactin release through a non-genomic mechanism involving interactions with the plasma membrane
    Borski, RJ
    Hyde, GN
    Fruchtman, S
    Tsai, WS
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 2001, 129 (2-3): : 533 - 541
  • [26] Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions
    Matsubara, Kazuo
    Shimizu, Keiko
    Suno, Manabu
    Ogawa, Kento
    Awaya, Toshio
    Yamada, Takehiro
    Noda, Toshihiro
    Satomi, Machiko
    Ohtaki, Ko-ichi
    Chiba, Kaoru
    Tasaki, Yoshikazu
    Shiono, Hiroshi
    BRAIN RESEARCH, 2006, 1112 : 126 - 133
  • [27] Evaluation of novel radiotracers targeting non-dopaminergic striatal biomarkers in HD: [18F]FPEB and PET imaging for metabotrophic glutamate receptor type 5 (mGluR5) in healthy subjects and subjects with Huntington's disease (HD)
    Russell, D. S.
    Jennings, D. L.
    Tamagnan, G.
    Alagilles, D.
    Carson, R. E.
    Barret, O.
    Batis, J.
    Koren, A.
    Zubal, G.
    Seibyl, J. P.
    Marek, K. L.
    MOVEMENT DISORDERS, 2010, 25 (07) : S391 - S392